Background: Previous studies evaluating the association of vitamin D-related genetic variants with breast cancer risk have produced inconsistent results.
Introduction
In recent years, the role of vitamin D in the etiology of breast cancer has been increasingly recognized because of its importance in cell proliferation, apoptosis, and differentiation in normal and malignant tumor cells NAD synthetase (NADSYN1), 7-dehydrocholestrol reductase (DHCR7), acyl-coenzyme A dehydrogenase (ACADSB), and the region of chromosome 10 harboring open-reading frame 88 (C10orf88); refs. 4, 5] and breast cancer risk. We comprehensively examined this association using data on more than 5,000 women from the Shanghai Breast Cancer GWAS (SBC-GWAS).
Materials and Methods

Study population
This study includes data from 5,242 Chinese women, aged 25 to 70 years, in the SBC-GWAS, which drew its data from women who participated in the Shanghai Breast Cancer Study (SBCS, phases I and II), a population-based case-control study. Detailed methods for the SBCS and the SBC-GWAS have been published elsewhere (6) . This study was approved by all participating institutions, and participants provided written informed consent.
Single-nucleotide polymorphism genotyping, selection, and imputation Genotyping information was generated using the Affymetrix 6.0 array as described in detail previously (6) . The 8 genes (CYP27B1, CYP27A1, CYP24A1, GC, CYP3A4, CYP2J2, CYP2R1, and VDR) evaluated in this study were selected on the basis of their potential biologic role in vitamin D metabolism and signaling as determined by literature review (2, 4) , as well as an informatics tool, the STRING database (version 8.3). In addition, we included genes (NADSYN1, ACADSB, DHCR7, and C10orf88) that have been associated with 25(OH)D concentration, as identified by recent GWASs (4, 5) . Single-nucleotide polymorphisms (SNP) were selected within the region 10 kb upstream of the transcription start site and 10 kb downstream from the end of each gene. A total of 559 SNPs (175 directly observed and 384 imputed) in these 12 vitamin D-related genes with a minor allele frequency of 5% or more were included in the analyses.
Statistical analysis
Descriptive statistics and genome-wide analyses were conducted within each sample set and in aggregate using SAS (version 9.2) and PLINK, respectively, as described (Tables 1 and 2 ). Linkage disequilibrium was assessed by Haploview.
Results
The mean age was 50.7 years for cases and 49.6 years for controls. As compared with controls, cases were more likely to have higher educational attainment, earlier age at menarche, later age at first birth and menopause, longer reproductive span, family history of breast cancer among first-degree relatives, and a higher waist-to-hip ratio (data not shown). Of the 559 SNPs in the 12 genes that we analyzed, only 6 SNPs (rs12570116 in ACADSB, rs10902845 in C10orf88, rs4760658 in VDR, and rs6091822, rs8124792, and rs6097809 in CYP24A1) were associated with breast cancer risk (P < 0.05 for all, Table 1 ). However, these nominally significant associations were not significant after accounting for multiple testing. We also found no association between breast cancer risk and the most extensively studied genetic polymorphisms (2), including Fok1 (rs10735810, also known as rs2228570), Bsm1 (rs1544410), Taq1 (rs731236), and Apa1 (rs7975232) in VDR and rs2296241 in CYP24A1 (data not shown). Of the 22 SNPs associated with 25(OH)D level identified by prior GWAS, none were associated with breast cancer risk in our population (Table 2) . Furthermore, in analyses stratified by menopausal status, physical activity, or dietary energy intake, no polymorphisms were associated with breast cancer risk (data not shown).
Discussion
To our knowledge, this is the first comprehensive examination of common genetic variations (559 SNPs) across 12 genes related to vitamin D metabolism and signaling and breast cancer risk. Overall, vitamin D pathway gene polymorphisms were not associated with breast cancer risk in our population. The suggestive association for 6 SNPs in the ACADSB, VDR, and CYP24A1 genes and C10orf88 could be due to chance and need to be further investigated in other populations.
Among the vitamin D pathway genes, VDR SNPs (Apa1: rs7975232, Bsm1: rs1544410, Taq1: rs731236, and Fok1: rs10735810) have been investigated extensively in relation to cancer risk, particularly among Europeanancestry populations (2, 3) . However, none of these SNPs were associated with breast cancer risk in our study. In a meta-analysis of 21 case-control studies (2) and in a pooling analysis of 6 prospective studies (3), breast cancer risk was associated with the VDR Fok1 polymorphism, however, the Cancer Prevention Study (CPS) II Nutrition Cohort in the United States did not find a relationship between any of these VDR SNPs and breast cancer risk among postmenopausal women (7). In addition, prior studies showed that CYP24A1 was overexpressed in breast carcinoma (8) . In our study, we also found no associations of CYP24A1 polymorphisms with breast cancer risk, consistent with the CPS II Nutrition Cohort (7) .
In a recent GWAS conducted among 5 European-ancestry cohorts in the United States, several SNPs in the GC, DHCR7/NADSYN, and CYP2R1 genes and C10orf88 (in the vicinity of ACADSB) were associated with 25(OH)D level (4) . Another GWAS [the Study of Underlying Genetic Determinants of Vitamin D and Highly Related Traits (SUNLIGHT)] of 15 cohorts among 33,996 individuals of European ancestry found an association for 3 other SNPs in DHCR7/NADSYN1, GC, and CYP2R1 (5). None of these 25(OH)D-associated gene variants were related to breast cancer risk in our population.
Strengths of this study include its large sample size, population-based design, comprehensive analysis involving multiple genes, and control of potential confounding variables. A limitation of this study is that we have no direct measurements of circulating 25(OH)D level or vitamin D status. In addition, our analysis was conducted among Chinese women and the results may not be generalizable to other ethnic groups/populations.
In conclusion, this comprehensive survey provides no strong evidence for the hypothesis that genetic variants in a set of genes related to vitamin D level and metabolism play an independent role in breast cancer development among Chinese women.
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